|
By printing and/or reading this article, you agree that you accept all terms and conditions of use, as specified online. First Drug Approved for IBS-C
Irritable bowel syndrome is a disorder characterized by cramping, abdominal pain, bloating, constipation, and diarrhea. IBS causes a great deal of discomfort and distress to its sufferers. It affects at least twice as many women as men. "For some people IBS can be quite disabling, making it difficult for them to fully participate in everyday activities," said Julie Beitz, M.D., director of the Office of Drug Evaluation III, Center for Drug Evaluation and Research, FDA. "This drug represents an important step in helping to provide medical relief from their symptoms." Amitiza is not approved for use in children and men. The drug was approved only for women because the clinical trials that led to its approval did not involve enough men to show that it was effective in men. Amitiza, like most prescription medications, is accompanied by some side effects. Common side effects of Amitiza include nausea, diarrhea and abdominal pain. Other rare side effects include urinary tract infections, dry mouth, syncope (fainting), peripheral edema (swelling of the extremities), dyspnea (difficulty breathing) and heart palpitations. (Read about "Urinary Tract Infections" "Oral Health" "Syncope") Note: Statements and conclusions of study authors that are published here are solely those of the study authors and do not necessarily reflect this hospital's policy or position. This hospital makes no representation or warranty as to their accuracy or reliability. All Concept Communications material is provided for information only and is neither advice nor a substitute for proper medical care. Consult a qualified healthcare professional who understands your particular history for individual concerns. © Concept Communications Media Group LLC Online health topics reviewed/modified in 2008 | Terms of Use/Privacy Policy By printing and/or reading this article, you agree that you accept all terms and conditions of use, as specified online.
|
|
||||||